200 related articles for article (PubMed ID: 33153773)
1. GABAergic polygenic risk for cocaine use disorder is negatively correlated with precuneus activity during cognitive control in African American individuals.
Yang BZ; Balodis IM; Kober H; Worhunsky PD; Lacadie CM; Gelernter J; Potenza MN
Addict Behav; 2021 Mar; 114():106695. PubMed ID: 33153773
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic group differences and exploratory sex differences in intrinsic connectivity during fMRI Stroop in individuals with and without cocaine use disorder.
Zakiniaeiz Y; Lacadie CM; Macdonald-Gagnon G; DeVito EE; Potenza MN
Drug Alcohol Depend; 2023 Oct; 251():110962. PubMed ID: 37716288
[TBL] [Abstract][Full Text] [Related]
3. Genetic Architecture and Molecular Neuropathology of Human Cocaine Addiction.
Huggett SB; Stallings MC
J Neurosci; 2020 Jul; 40(27):5300-5313. PubMed ID: 32457073
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal changes in network engagement during cognitive control in cocaine use disorder.
Morie KP; DeVito EE; Potenza MN; Worhunsky PD
Drug Alcohol Depend; 2021 Dec; 229(Pt A):109151. PubMed ID: 34753083
[TBL] [Abstract][Full Text] [Related]
5. Basal Hippocampal Activity and Its Functional Connectivity Predicts Cocaine Relapse.
Adinoff B; Gu H; Merrick C; McHugh M; Jeon-Slaughter H; Lu H; Yang Y; Stein EA
Biol Psychiatry; 2015 Oct; 78(7):496-504. PubMed ID: 25749098
[TBL] [Abstract][Full Text] [Related]
6. Emotion recognition in individuals with cocaine use disorder: the role of abstinence length and the social brain network.
Rabin RA; Parvaz MA; Alia-Klein N; Goldstein RZ
Psychopharmacology (Berl); 2022 Apr; 239(4):1019-1033. PubMed ID: 34089343
[TBL] [Abstract][Full Text] [Related]
7. Alterations in functional brain networks associated with loss-chasing in gambling disorder and cocaine-use disorder.
Worhunsky PD; Potenza MN; Rogers RD
Drug Alcohol Depend; 2017 Sep; 178():363-371. PubMed ID: 28697386
[TBL] [Abstract][Full Text] [Related]
8. A preliminary investigation of Stroop-related intrinsic connectivity in cocaine dependence: associations with treatment outcomes.
Mitchell MR; Balodis IM; Devito EE; Lacadie CM; Yeston J; Scheinost D; Constable RT; Carroll KM; Potenza MN
Am J Drug Alcohol Abuse; 2013 Nov; 39(6):392-402. PubMed ID: 24200209
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment in individuals with bipolar disorder with and without comorbid alcohol and/or cocaine use disorders.
Li C; Palka JM; Brown ES
J Affect Disord; 2020 Jul; 272():355-362. PubMed ID: 32553378
[TBL] [Abstract][Full Text] [Related]
10. Neural Correlates of Drug-Biased Choice in Currently Using and Abstinent Individuals With Cocaine Use Disorder.
Moeller SJ; Zilverstand A; Konova AB; Kundu P; Parvaz MA; Preston-Campbell R; Bachi K; Alia-Klein N; Goldstein RZ
Biol Psychiatry Cogn Neurosci Neuroimaging; 2018 May; 3(5):485-494. PubMed ID: 29735157
[TBL] [Abstract][Full Text] [Related]
11. Brain multimodal co-alterations related to delay discounting: a multimodal MRI fusion analysis in persons with and without cocaine use disorder.
Meade CS; Li X; Towe SL; Bell RP; Calhoun VD; Sui J
BMC Neurosci; 2021 Aug; 22(1):51. PubMed ID: 34416865
[TBL] [Abstract][Full Text] [Related]
12. Altered amygdala-cortical connectivity in individuals with Cannabis use disorder.
Aloi J; McCusker MC; Lew BJ; Schantell M; Eastman JA; Frenzel MR; Wilson TW
J Psychopharmacol; 2021 Nov; 35(11):1365-1374. PubMed ID: 34730052
[TBL] [Abstract][Full Text] [Related]
13. Neural mechanisms of risky decision-making and reward response in adolescent onset cannabis use disorder.
De Bellis MD; Wang L; Bergman SR; Yaxley RH; Hooper SR; Huettel SA
Drug Alcohol Depend; 2013 Nov; 133(1):134-45. PubMed ID: 23773952
[TBL] [Abstract][Full Text] [Related]
14. Repurposing ketamine to treat cocaine use disorder: integration of artificial intelligence-based prediction, expert evaluation, clinical corroboration and mechanism of action analyses.
Gao Z; Winhusen TJ; Gorenflo M; Ghitza UE; Davis PB; Kaelber DC; Xu R
Addiction; 2023 Jul; 118(7):1307-1319. PubMed ID: 36792381
[TBL] [Abstract][Full Text] [Related]
15. Glutamatergic and GABAergic susceptibility loci for heroin and cocaine addiction in subjects of African and European ancestry.
Levran O; Peles E; Randesi M; Correa da Rosa J; Ott J; Rotrosen J; Adelson M; Kreek MJ
Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():118-23. PubMed ID: 26277529
[TBL] [Abstract][Full Text] [Related]
16. Effects of attentional bias modification therapy on the cue reactivity and cognitive control networks in participants with cocaine use disorders.
Mayer AR; Dodd AB; Wilcox CE; Klimaj SD; Claus ED; Bryan AD
Am J Drug Alcohol Abuse; 2020 May; 46(3):357-367. PubMed ID: 31730369
[TBL] [Abstract][Full Text] [Related]
17. Altered resting-state functional connectivity of the right precuneus and cognition between depressed and non-depressed schizophrenia.
Li P; Zhou M; Yan W; Du J; Lu S; Xie S; Zhang R
Psychiatry Res Neuroimaging; 2021 Nov; 317():111387. PubMed ID: 34509807
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders.
García-Marchena N; Barrera M; Mestre-Pintó JI; Araos P; Serrano A; Pérez-Mañá C; Papaseit E; Fonseca F; Ruiz JJ; Rodríguez de Fonseca F; Farré M; Pavón FJ; Torrens M
PLoS One; 2019; 14(3):e0213791. PubMed ID: 30870525
[TBL] [Abstract][Full Text] [Related]
19. Effects of chronic and acute stimulants on brain functional connectivity hubs.
Konova AB; Moeller SJ; Tomasi D; Goldstein RZ
Brain Res; 2015 Dec; 1628(Pt A):147-56. PubMed ID: 25721787
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled trial of ondansetron for the treatment of cocaine use disorder with post hoc pharmacogenetic analysis.
Blevins D; Seneviratne C; Wang XQ; Johnson BA; Ait-Daoud N
Drug Alcohol Depend; 2021 Nov; 228():109074. PubMed ID: 34600264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
